牙髓卟啉单胞菌与牙龈卟啉单胞菌LPS经TLR2/4促血管生成
本研究为体外实验,评估牙髓卟啉单胞菌(ATCC 35406及临床分离株)与牙龈卟啉单胞菌LPS是否经TLR2和TLR4诱导内皮细胞血管生成相关效应。结果显示牙髓卟啉单胞菌LPS促内皮细胞迁移、FAK Y397磷酸化及小管形成,两种菌LPS均诱导IL-6与VEGF-A合成,TLR2/4参与其中。
要点
- 牙髓卟啉单胞菌LPS可促内皮细胞迁移,牙龈卟啉单胞菌LPS未显示此作用
- 两种LPS均以TLR2/4依赖方式诱导内皮小管形成
- VEGF-A合成不依赖TLR信号,IL-6诱导部分依赖TLR2/4
核心结论
- 牙髓卟啉单胞菌和牙龈卟啉单胞菌LPS经TLR2和TLR4途径在体外诱导血管生成。
研究设计与样本
- 体外研究:纯化牙髓卟啉单胞菌LPS(ATCC 35406与临床分离株),牙龈卟啉单胞菌LPS为商品化来源。
- 采用Transwell迁移实验(40×光镜定量)、Western blotting检测FAK Y397磷酸化、Matrigel小管形成实验(14 h)、多重微珠免疫检测IL-6与VEGF-A,并用阻断抗体评估TLR2/TLR4作用。
主要发现
- 牙髓卟啉单胞菌LPS而非牙龈卟啉单胞菌LPS刺激内皮细胞迁移,抗TLR2和抗TLR4抗体预处理可阻止该迁移。
- 牙髓卟啉单胞菌LPS促进FAK Y397磷酸化,表现为p-FAK/FAK比值升高。
- 两种菌LPS(牙髓卟啉单胞菌为ATCC 35406)均以TLR2和TLR4依赖方式诱导内皮小管形成,但临床分离株诱导的小管形成仅被TLR2阻断所降低。
- 所有LPS均诱导内皮细胞合成IL-6和VEGF-A;牙髓卟啉单胞菌LPS(ATCC 35406)诱导IL-6需TLR2和TLR4,其他LPS的IL-6分泌仅涉及TLR4。
- VEGF-A合成不需要TLR信号。
临床怎么用
- 提示牙髓卟啉单胞菌与牙龈卟啉单胞菌LPS可能通过TLR2/4促进根尖周炎和牙周炎相关血管生成,为机制研究提供线索,尚不能直接指导临床用药。
局限性
- 研究为体外实验,不能直接外推到体内或临床。
- 未提供样本量、P值等统计细节,结论需进一步体内研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Angiogenesis contributes to the development of apical periodontitis, periodontitis, and other oral pathologies; however, it remains unclear how this process is triggered. The aim was to evaluate whether lipopolysaccharide (LPS) from Porphyromonas endodontalis and Porphyromonas gingivalis induced angiogenesis-related effects in vitro via TLR2 and TLR4. METHODOLOGY: Porphyromonas endodontalis LPS (ATCC 35406 and clinical isolate) was purified with TRIzol, whereas P. gingivalis LPS was obtained commercially. The effects of the different LPS (24 h) in endothelial cell migration were analysed by Transwell assays, following quantification in an optical microscope (40×). The effects of LPS on FAK Y397 phosphorylation were assessed by Western blotting. Angiogenesis in vitro was determined in an endothelial tube formation assay (14 h) in Matrigel in the absence or presence of either LPS. IL-6 and VEGF-A levels were determined in cell supernatants, following 24 h treatment with LPS, and measured in multiplex bead immunoassay. The involvement of TLR2 and TLR4 was assessed with blocking antibodies. The statistical analysis was performed using STATA 12® (StataCorp LP). RESULTS: The results revealed that P. endodontalis LPS, but not P. gingivalis LPS, stimulated endothelial cell migration. Pre-treatment with anti-TLR2 and anti-TLR4 antibodies prevented P. endodontalis LPS-induced cell migration. P. endodontalis LPS promoted FAK phosphorylation on Y397, as observed by an increased p-FAK/FAK ratio. Both P. gingivalis and P. endodontalis LPS (ATCC 35406) induced endothelial tube formation in a TLR-2 and -4-dependent manner, as shown by using blocking antibodies, however, only TLR2 blocking decreased tube formation induced by P. endodontalis (clinical isolate). Moreover, all LPS induced IL-6 and VEGF-A synthesis in endothelial cells. TLR2 and TLR4 were required for IL-6 induction by P. endodontalis LPS (ATCC 35406), while only TLR4 was involved in IL-6 secretion by the other LPS. Finally, VEGF-A synthesis did not require TLR signalling. CONCLUSION: Porphyromonas endodontalis and P. gingivalis LPS induced angiogenesis via TLR2 and TLR4. Collectively, these data contribute to understanding the role of LPS from Porphyromonas spp. in angiogenesis and TLR involvement.
引用
- Fernández A, Herrera D, Hoare A, et al. Lipopolysaccharides from Porphyromonas endodontalis and Porphyromonas gingivalis promote angiogenesis via Toll-like-receptors 2 and 4 pathways in vitro. Int Endod J. 2023. PMID: 37461231. doi:10.1111/iej.13957
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。